Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2026-03-03 @ 12:44 AM
Study NCT ID:
NCT01067469
Status:
COMPLETED
Last Update Posted:
2020-03-17
First Post:
2010-02-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
Sponsor:
Organization: